| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |